PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,810 | -30.1% | 62,021 | 0.0% | 0.00% | – |
| Q2 2023 | $58,380 | -49.7% | 62,021 | -48.8% | 0.00% | – |
| Q1 2023 | $116,114 | +41.1% | 121,242 | +103.3% | 0.00% | – |
| Q4 2022 | $82,317 | +8.3% | 59,650 | -1.6% | 0.00% | – |
| Q3 2022 | $76,000 | -46.9% | 60,650 | -0.2% | 0.00% | – |
| Q2 2022 | $143,000 | -87.8% | 60,758 | -83.9% | 0.00% | – |
| Q1 2022 | $1,172,000 | -89.7% | 378,160 | -78.9% | 0.00% | -100.0% |
| Q4 2021 | $11,380,000 | -79.7% | 1,792,044 | -68.2% | 0.00% | -75.0% |
| Q3 2021 | $56,101,000 | -35.4% | 5,632,556 | -14.2% | 0.00% | -42.9% |
| Q2 2021 | $86,899,000 | -38.4% | 6,563,308 | -18.7% | 0.01% | -41.7% |
| Q1 2021 | $141,147,000 | +4.6% | 8,074,687 | +53.0% | 0.01% | 0.0% |
| Q4 2020 | $134,961,000 | +117.7% | 5,278,100 | +11.6% | 0.01% | +100.0% |
| Q3 2020 | $62,007,000 | -52.4% | 4,729,730 | -0.8% | 0.01% | -57.1% |
| Q2 2020 | $130,321,000 | +164.0% | 4,768,445 | +52.1% | 0.01% | +100.0% |
| Q1 2020 | $49,363,000 | – | 3,134,124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |